Doogan Declan
SEC insider (Form 3/4/5 filer). CIK 0001704234. Director at TENAX THERAPEUTICS, INC. (TENX). 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 16, 2026. Located in CHAPEL HILL, NC.
Companies Doogan Declan has filed insider reports for
- TENAX THERAPEUTICS, INC. (TENX): Director
Doogan Declan
CIK: 0001704234
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TENAX THERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 16, 2026TENX
TENAX THERAPEUTICS, INC.
PurchaseDirect53K shares at avg. $1.92$102K - Jan 9, 2026TENX
TENAX THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
30K shares- - Jul 1, 2025TENX
TENAX THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
80K shares- - Dec 10, 2024TENX
TENAX THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
100K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 16, 2026 | TENX TENAX THERAPEUTICS, INC. | Purchase | 53,000 | $1.92 | $101,760 | Direct |
| Jan 9, 2026 | TENX TENAX THERAPEUTICS, INC. | Award Stock Option (right to buy) | 30,000 | - | - | Direct |
| Jul 1, 2025 | TENX TENAX THERAPEUTICS, INC. | Award Stock Option (right to buy) | 80,000 | - | - | Direct |
| Dec 10, 2024 | TENX TENAX THERAPEUTICS, INC. | Award Stock Option (right to buy) | 100,000 | - | - | Direct |
1-4 of 4 transactions